BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Bone cancer AND CDKN2C, P42773, 1031, ENSG00000123080, INK4C, p18, p18-INK4C AND Treatment
14 results:

  • 1. Fertility preservation and fulfillment of parenthood after treatment of hematological malignancies: results from the 'Aftercare in Blood cancer Survivors' (ABC) study.
    Schmitz C; Baum J; Lax H; Lehmann N; Gromke T; Beelen DW; Jöckel KH; Dührsen U
    Int J Clin Oncol; 2020 Jun; 25(6):1187-1194. PubMed ID: 32140954
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Knowledge, beliefs, and concerns about bone health from a systematic review and metasynthesis of qualitative studies.
    des Bordes J; Prasad S; Pratt G; Suarez-Almazor ME; Lopez-Olivo MA
    PLoS One; 2020; 15(1):e0227765. PubMed ID: 31940409
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Comprehensive Genomic Profiling of Esthesioneuroblastoma Reveals Additional treatment Options.
    Gay LM; Kim S; Fedorchak K; Kundranda M; Odia Y; Nangia C; Battiste J; Colon-Otero G; Powell S; Russell J; Elvin JA; Vergilio JA; Suh J; Ali SM; Stephens PJ; Miller VA; Ross JS
    Oncologist; 2017 Jul; 22(7):834-842. PubMed ID: 28495808
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Optimizing Therapeutic Effect of Aurora B Inhibition in Acute Myeloid Leukemia with AZD2811 Nanoparticles.
    Floc'h N; Ashton S; Taylor P; Trueman D; Harris E; Odedra R; Maratea K; Derbyshire N; Caddy J; Jacobs VN; Hattersley M; Wen S; Curtis NJ; Pilling JE; Pease EJ; Barry ST
    Mol Cancer Ther; 2017 Jun; 16(6):1031-1040. PubMed ID: 28292940
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Array-CGH predicts prognosis in plasma cell post-transplantation lymphoproliferative disorders.
    Sarkozy C; Kaltenbach S; Faurie P; Canioni D; Berger F; Traverse-Glehen A; Ghesquieres H; Salles G; Bachy E; Alyanakian MA; Hermine O; Neven B; Macintyre E; Romana S; Molina TJ; Suarez F; Asnafi V; Bruneau J
    Genes Chromosomes Cancer; 2017 Mar; 56(3):221-230. PubMed ID: 27750397
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. A case of simultaneous occurrence of acute myeloid leukemia and multiple myeloma.
    Lu-Qun W; Hao L; Xiang-Xin L; Fang-Lin L; Ling-Ling W; Xue-Liang C; Ming H
    BMC Cancer; 2015 Oct; 15():724. PubMed ID: 26474569
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Angiopoietin1 contributes to the maintenance of cell quiescence in EVI1(high) leukemia cells.
    Ichihara E; Kaneda K; Saito Y; Yamakawa N; Morishita K
    Biochem Biophys Res Commun; 2011 Dec; 416(3-4):239-45. PubMed ID: 22033412
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. [Central nervous system lymphoma and its significance].
    Zheng W; Lin NJ; Xie Y; Wang XP; Tu MF; Liu WP; Song YQ; Ping LY; Ying ZT; Deng LJ; Zhang C; Zhu J
    Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(22):1550-4. PubMed ID: 21914369
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Evaluation of surgical management of primary spinal tumours.
    Chowdhury AZ; Hossain MT; Chowdhury AI; Salek KM; Kaiser MS; Arifin KN
    Mymensingh Med J; 2010 Oct; 19(4):594-600. PubMed ID: 20956905
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Apoptotic cell death in TrkA-overexpressing cells: kinetic regulation of ERK phosphorylation and caspase-7 activation.
    Jung EJ; Kim DR
    Mol Cells; 2008 Jul; 26(1):12-7. PubMed ID: 18511888
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Mutually exclusive cyclin-dependent kinase 4/cyclin D1 and cyclin-dependent kinase 6/cyclin D2 pairing inactivates retinoblastoma protein and promotes cell cycle dysregulation in multiple myeloma.
    Ely S; Di Liberto M; Niesvizky R; Baughn LB; Cho HJ; Hatada EN; Knowles DM; Lane J; Chen-Kiang S
    Cancer Res; 2005 Dec; 65(24):11345-53. PubMed ID: 16357141
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.
    Haudenschild DR; Palmer SM; Moseley TA; You Z; Reddi AH
    Cancer Res; 2004 Nov; 64(22):8276-84. PubMed ID: 15548695
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prednimustine (NSC-134087, Leo 1031) treatment of lymphocytic and lymphocytic-histiocytic lymphomas.
    Mattsson W; von Eyben F; Turesson I; Wählby S
    Cancer; 1978 Jan; 41(1):112-6. PubMed ID: 342081
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Therapeutic effect of Leo 1031, an alkylating corticosteroid ester; in lymphoproliferative disorders. II. Lymphocytic lymphoma.
    Móller TR; Brandt L; Kónyves I; Lindberg G
    Acta Med Scand; 1975 Apr; 197(4):323-7. PubMed ID: 1173538
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.